Business
Final Results
Final Results.
About this update from Spirax Group Plc.
[{"type":"text","content":"\n \nRNS Number : 0959S Spirax-Sarco Engineering PLC 07 March 2019 \n\n \n \n \nNews Release\nThursday 7th March 2019\n \nStrong organic growth and full-year contributions from acquisitions\n \nHIGHLIGHTS\n \n\n\n\n\nAdjusted*\n\n\n2018\n\n\n2017\n\n\nReported\n\n\nOrganic⁺\n\n\n\n\nRevenue\n\n\n£1,153.3m\n\n\n£998.7m\n\n\n+15%\n\n\n+7%\n\n\n\n\nAdjusted operating profit* \n\n\n£264.9m\n\n\n£235.5m\n\n\n+12%\n\n\n +12%\n\n\n\n\nAdjusted operating profit margin*\n\n\n23.0%\n\n\n23.6%\n\n\n-60 bps\n\n\n+120 bps\n\n\n\n\nAdjusted profit before taxation* \n\n\n£254.6m\n\n\n£229.1m\n\n\n+11%\n\n\n \n\n\n\n\nAdjusted basic earnings per share*\n\n\n250.0p\n\n\n220.5p\n\n\n+13%\n\n\n \n\n\n\n\nDividend per share\n\n\n100.0p\n\n\n87.5p\n\n\n +14%\n\n\n \n\n\n\n\nCash conversion**\n\n\n 91%\n\n\n 86%\n\n\n \n\n\n \n\n\n\n\n \n*All profit measures exclude certain items which totalled £34.2 million for the year ended 31st December 2018, as set out and explained in the Financial Review and in Note 2.\n**Cash conversion measures the percentage of adjusted cash from operations to adjusted operating profit as explained in the Financial Review and in Note 2.\n⁺ Organic percentage growth measures are at constant currency and exclude contributions from acquisitions and disposals. \n \n\n\n\n\nStatutory\n\n\n2018\n\n\n2017\n\n\nReported\n\n\n\n\nRevenue\n\n\n£1,153.3m\n\n\n£998.7m\n\n\n+15%\n\n\n\n\nOperating profit \n\n\n£299.1m\n\n\n£198.9m\n\n\n+50%\n\n\n\n\nOperating profit margin\n\n\n25.9%\n\n\n19.9%\n\n\n+600 bps\n\n\n\n\nProfit before taxation \n\n\n£288.8m\n\n\n£192.5m\n\n\n+50%\n\n\n\n\nBasic earnings per share\n\n\n303.1p\n\n\n214.4p\n\n\n+41%\n\n\n\n\n \n \n\n\n\n\n· \n\n\nRevenue growth of 15%, organic sales growth of 7%\n\n\n\n\n· \n\n\nAdjusted operating margin of 23.0%, down 60 bps; organic margin up 120 bps to 25.2%\n\n\n\n\n· \n\n\nStrong organic sales growth in Steam Specialties and Watson-Marlow\n\n\n\n\n· \n\n\nGestra and Chromalox performing well\n\n\n\n\n· \n\n\n...